28 March 2019

Jeroen van der Laak awarded as Nathan Kaufman timely topics lecturer 2019 at the annual meeting of the United States and Canadian Academy of Pathology (USCAP).

His keynote lecture titled 'The Rise of Artificial Intelligence: Impact on Advanced Diagnostics in Health Care' was held inside the impressive Potomac Ballroom, in the Gaylord National Resort & Convention Center at the National Harber, Maryland. The lecture was witnessed by 3500 clinicians, researchers and other interested parties. His research group investigates the use of deep learning based analysis of whole slide images for different applications: improvement of routine pathology diagnostics, objective quantification of immunohistochemical markers, and study of novel imaging biomarkers for prognostics. The Nathan Kaufman Timely Topics Lecture is presented during the Annual Meeting of USCAP. The lecturer should be well recognized and respected within the medical community, in general, and by the pathology community; he/she should be capable of giving a lucid and erudite lecture relating to topics of contemporary interest. This lecture is regarded as an honor within the USCAP sphere.

Jeroen van der Laak is member of theme Women's cancers.

Related news items


Ioannis Sechopoulos receives NWO Vici grant for research on improving breast cancer diagnostics

1 March 2022 Ioannis Sechopoulos will conduct research into improving tomosynthesis, an X-ray examination that radiologists use to detect breast cancer. read more

1.4 million euro to reduce hospital admissions due to medication

7 January 2022 A team of sixteen Dutch hospitals received a grant of 1.4 million euros from ZonMw. They will investigate whether they can reduce medication related hospital readmissions. read more

Mireille Broeders appointed member of the Dutch Health Council

16 November 2021 Mireille Broeders, professor of Personalized Cancer Screening, has been appointed as a member of the permanent Committee on Population Screening of the Dutch Health Council (Gezondheidsraad). read more

2.5 million Euros for cancer research into ovarian cancer and immunotherapy

15 April 2021 The Radboudumc receives 2.5 million Euros from the Dutch Cancer Society (KWF) for three studies to ensure oncological progress during COVID-19 period. read more

First graduation in 'de Aula' in accordance with new guidelines

4 June 2020 On Wednesday 3 June, the first Radboudumc-graduation took place in 'de Aula' in accordance with the new RIVM guidelines. read more

Supplemental MRI screening for women with extremely dense breast tissue

9 January 2020 In the New England Journal of Medicine, the DENSE trial study group including RIHS researchers Ritse Mann and Nico Karssemeijer showed that additional MRI after the nationwide breast screening, reduces interval breast cancer in women with extremely dense breast tissue. read more